4544
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

H.U. Group Holdings, Inc. is a holding company operating in clinical testing, in vitro diagnostics, and healthcare-related services. Its business segments include Lab Testing and related Services (LTS), In Vitro Diagnostics (IVD), and Healthcare-related Services (HS). The LTS segment provides outsourced clinical testing to hospitals and clinics, health checkup management solutions, and testing for food, environmental, and cosmetic samples. The IVD segment involves the manufacturing and sales of clinical test reagents, contract development and manufacturing organization (CDMO) services, and the supply of raw materials and bio-ingredients to diagnostic and pharmaceutical companies globally. The HS segment covers sterilization and surgical support services for hospitals, as well as home-based nursing and care services. The group serves medical institutions, diagnostic laboratories, pharmaceutical companies, and corporate clients in Japan and internationally, including the United States and Europe.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Diagnostics & Research Homepage hugp.com
Sector Healthcare IR page hugp.com
Tags
clinical testing, in vitro diagnostics, cdmo, sterilization services, home care, genetic testing, food testing, pathology testing, bio-ingredients, surgical support, H.U. Frontier, SRL, Fujirebio Holdings, Nippon Steri, Nippon Medical Clinical Laboratory, Tokyo Central Pathology Laboratory, Baylor Miraca Genetics Laboratories, H.U. America, Baylor Genetics Holdings, H.U. Wellness, Nippon Food Ecology Laboratory, Fujirebio, Fujirebio Diagnostics Japan, Senshin Life Science Research Institute, Fujirebio Diagnostics, Plasma Services Group, Fujirebio Europe, ADx NeuroSciences, Fluxus, StarQ Gaia, StarQ Care, Gaia Medical Care, Lumipulse
Press page hugp.com/news

Metrics

Valuation  
Market cap ¥ 200.242B
Market cap (USD) $ 1.252B
P/E 19.47
PEG —
P/BV 1.53
P/S 0.80
P/OCF 8.20
P/FCF 10.36
Dividend yield 3.6%
Turnover / mcap —
Returns  
ROE 5.0%
ROI 4.4%
ROIC 2.4%
Profit margin 2.8%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -24.2%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 6
Quality score 0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 247.362B 243.025B 236.95B 260.908B 272.944B 223.016B 188.712B 181.415B 195.4B 204.245B 211.743B 204.667B 203.371B 192.211B
Net profit 6.823B 2.761B -7.553B 15.676B 29.599B 17.468B -516M 6.386B 257M 333M -5.081B 16.002B 15.322B 14.871B
Free cash flow 16.703B 11.65B -1.006B 10.849B 20.104B 24.058B -336M -10.465B -1.527B 28.282B 17.046B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 3.191K 2.745K 2.444K 2.667K 2.905K 3.716K 2.277K 2.746K 4.155K 5.12K 4.624K 5.53K 4.521K 4.586K
Price performance 12m 0.16 0.12 -0.08 -0.08 -0.22 0.63 -0.17 -0.34 -0.19 0.11 -0.16 0.22 -0.01 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 36.6B 31.9B 34.1B 32.7B 46.6B 116B 90.9B 91.7B 89.8B 89.8B
↳ YoY growth -1.1% -12.8% +7.1% -4.1% +42.4% +149.1% -21.7% +0.8% -2.1% +0.0%
↳ 5y CAGR +4.8% +26.0% +23.3% +21.8% +22.4% +14.0%
Borrowings, current (JPY) 2B 2B 16.5B 14.2B 8.4B 3.62B 3.7B 10B 20B 25B
Borrowings, non-current (JPY) 4.3B 2.3B 30.4B 51.2B 57.3B 53.7B 60B 60.1B 50.3B 35.3B
Bonds payable (JPY) — — 15B 35B 35B 35B 35B 41.1B 31.1B 31.1B
Lease liabilities (JPY) 3.95B 3.8B 3.04B 6.14B 14.7B 15.7B 13.5B 11.8B 16.3B 14B
Cash and deposits (JPY) 26.6B 20.5B 33.7B 36.4B 43B 46.5B 44.2B 39.9B 40.9B 48.1B
Intangible assets (JPY) 56.7B 11.4B 15.1B 21B 27.5B 34.4B 45.4B 45.8B 44.3B 39.7B
Net debt (borrowings + leases - cash) (JPY) -16.3B -12.4B 16.2B 35.2B 37.5B 26.5B 33B 42B 45.8B 26.2B
Cash flow detail
Operating cash flow (JPY) 36.4B 15.8B 16.2B 15.2B 35.6B 55.2B 32.5B 16.6B 22B 21.6B
Purchases of property, plant and equipment (JPY) -4.38B -14.8B -21.4B -8.1B -11.5B -23.7B -14.2B -12.4B -4.08B -2.36B
Purchases of intangible assets (JPY) -3.77B -2.54B -5.35B -7.47B -9.66B -11.4B -7.45B -5.19B -6.23B -2.51B
Change in receivables (cash effect) (JPY) 416M -1.71B -2.46B 881M -13.9B — 12.9B 640M 237M -295M
Change in inventories (cash effect) (JPY) 66M -894M -1.35B -2.91B -637M -286M -2.04B 787M 1.06B -1.66B
Change in payables (cash effect) (JPY) -775M 333M 995M 1.91B 6.58B 1.94B -103M -1.77B -1.59B 933M
Dividends paid (cash effect) (JPY) -6.37B -6.95B -7.41B -7.42B -6.56B -8.91B -7.14B -7.14B -7.14B -7.14B
Share buybacks (cash effect) (JPY) — -8M -395M — -2M -498M -1M -987M -1M -5B
Interest paid (cash effect) (JPY) -504M -334M -150M -223M -306M -397M — -389M -615M -706M
Income taxes paid (cash effect) (JPY) -2.21B -6.97B 817M -9B 5.51B -5.75B -21B 5.93B -2.59B -2.35B
Operating cash flow before change in receivables (JPY) 36B 17.5B 18.7B 14.3B 49.5B — 19.6B 15.9B 21.7B 21.9B
Free cash flow (OCF - PPE - intangibles) (JPY) 28.3B -1.53B -10.5B -336M 14.4B 20.1B 10.8B -1.01B 11.7B 16.7B
Income detail
Research and development expense (JPY) 4.75B 5.37B 5.94B 5.51B 5.94B 7.28B 9.56B 11.3B 10.9B 11.2B
↳ 5y CAGR +0.8% +8.9% +12.2% +13.7% +14.6% +13.4%
Total comprehensive income (JPY) -1.42B -28.1B 7.51B -2.46B 18.9B 34.2B 17B -199M 1.62B 12.3B
Comprehensive income to owners (JPY) -1.42B -28.1B 7.51B -2.46B 19B 34.2B 17B -199M 1.65B 12.4B
Provision for credit losses (JPY) — — — — — — — 144M 295M —
Credit cost ratio (credit losses / average receivables) (%) — — — — — — — 0.2% 0.3% —
Reported Jun 22, 2018 Jun 21, 2019 Jun 21, 2019 Jun 24, 2020 Jun 22, 2022 Jun 22, 2022 Jun 19, 2024 Jun 16, 2025 Jun 15, 2026 Jun 15, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

H.U. Group Holdings, Inc. (ticker 4544), listed in Japan.

ETFs Holding H.U. Group Holdings, Inc.

ETF Weight in ETF Shares Market value As of
AVDS 0.06% 8,300 $ 209.054K Nov 16, 2026
AVSD 0.04% 5,600 $ 141.048K Nov 16, 2026
DFIS 0.04% 82,701 $ 2.065M Nov 12, 2026
AVDE 0.02% 119,200 $ 3.002M Nov 16, 2026
DXIV 0.02% 1,900 $ 47.447K Nov 12, 2026
DFIC 0.02% 113,600 $ 2.837M Nov 12, 2026
DFAX 0.01% 46,100 $ 1.151M Nov 12, 2026
DFSI 0.01% 4,000 $ 99.887K Nov 12, 2026
DFAI 0.01% 45,600 $ 1.139M Nov 12, 2026
DISV 0.00% 99 $ 2,472.21 Nov 12, 2026